Rap legend Eminem has yet to confirm any world tour dates for 2026, despite a flood of online rumors, fake announcements and fan-generated schedules circulating on social media and unofficial websites. As of mid-March 2026, the artist’s official website, Ticketmaster and Live Nation listings show no upcoming concerts or tour plans for Marshall Mathers, leaving fans eagerly awaiting word on whether the Detroit native will hit the road following his 2024 album “The Death of Slim Shady (Coup de Grâce).”
Multiple Facebook posts, Instagram reels and fan sites claimed in early March that Eminem announced a major 2026 world tour, often describing 30-40 dates across North America, Europe and Australia. Some posts suggested kickoffs at London’s O2 Arena or Detroit’s Ford Field, with stops in New York, Tokyo, Berlin, Paris and Sydney. Others labeled it a “farewell” or “one last ride” tour, even naming hypothetical starts like April 12, 2026, at Ford Field and endings in October at Marvel Stadium in Melbourne. Several included detailed — but unverified — venue lists featuring stadiums like Soldier Field in Chicago, MetLife Stadium in New Jersey and Gillette Stadium in Massachusetts.
Reliable sources contradict these claims. Ticketmaster’s Eminem page lists zero upcoming concerts, stating “No Upcoming Concerts” and directing users to check back. Live Nation’s artist page for Eminem similarly shows no 2026 tour schedule. The official eminem.com site, last updated in March 2026 with merchandise news like Stan dog tag pendants and a February release of “The Shady LPs,” contains no tour announcements, dates or ticket information. Major ticketing platforms and promoter sites remain silent on any confirmed shows.
The surge in rumors appears tied to fan excitement after Eminem’s recent activity. His 2024 album, featuring the hit single “Houdini,” marked a conceptual close to his Slim Shady persona and included high-profile collaborations. A November 2025 Thanksgiving halftime show performance and ongoing merchandise drops have kept momentum alive. Fans on Reddit and X speculate that anniversary milestones — such as reflections on past albums — could prompt a tour announcement, but no credible leaks from Shady Records or Eminem’s team support 2026 plans.
Tribute acts and unofficial events add to the confusion. Listings for “The Eminem Experience,” Michael Mathers tributes and Shady tribute shows appear on Ticketmaster and other platforms for 2026 dates in the U.K., Europe and Canada, including stops in Norwich, Hertford and Las Vegas. These performances mimic Eminem’s style but are not affiliated with the artist, leading some to mistake them for official concerts.
Advertisement
Eminem’s live history shows a selective approach. His last major tour was the 2019 *Rapture* run, with subsequent appearances limited to festivals, surprise sets and one-off events like Coachella. He has not embarked on a full world tour in recent years, preferring high-impact shows over extensive travel. This pattern fuels skepticism about large-scale 2026 plans, especially without official promotion or presale announcements.
Some viral posts suggest joint tours with Dr. Dre, Snoop Dogg and 50 Cent, calling it “Hip-Hop’s Ultimate Global Takeover.” Community notes on platforms like Instagram flag these as unconfirmed, with no statements from any involved artists. Such collaborations would represent a massive event, but lack substantiation from verified channels.
For fans hoping to see Eminem live, monitoring official sources remains key. The artist’s website, social media accounts and trusted ticketing partners like Ticketmaster offer the only reliable updates. Past patterns show Eminem often announces tours with little advance warning, sometimes tied to new releases or special occasions.
As speculation builds, the absence of concrete dates highlights the gap between fan enthusiasm and official confirmation. Eminem’s enduring catalog — from early battle-rap roots to chart-topping anthems — keeps demand high, but until an announcement arrives, 2026 concert plans stay in the realm of rumor. Stans worldwide continue refreshing feeds, hoping the next update brings long-awaited stage returns.
Advertisement
Should dates emerge, expect high demand for tickets, VIP packages and resale markets. For now, the word from Detroit is clear: no tour confirmed, but the conversation — and anticipation — rages on.
Center for Medicare Director Chris Klomp joins ‘Mornings with Maria’ to outline the Trump administration’s latest Medicare rate update, defend new efforts to curb rising healthcare costs and highlight ongoing moves to lower prescription drug prices a
Falling prescription drug costs are emerging as a key development in the broader push to rein in U.S. health care spending, with new pricing shifts beginning to show up at the pharmacy counter.
Medicare Director Chris Klomp joined FOX Business’ Maria Bartiromo on “Mornings with Maria” to discuss how recent policy changes are starting to impact affordability across the health care system.
Klomp pointed to early signs that pricing pressure is easing, particularly for high-demand medications like GLP-1 drugs, which have surged in popularity but have remained out of reach for many patients. He attributed the recent price declines to actions taken by President Donald Trump to lower drug costs through new pricing initiatives.
FOX Business’ Gerri Willis reports on a Gallup poll showing 61% of Americans are greatly concerned about rising healthcare costs, surpassing worries about the economy and inflation.
“If you need a GLP-1, you’re now paying half of what you were paying just a couple of months ago before he announced those deals,” Klomp said.
Advertisement
Klomp framed the pricing changes as part of a broader effort to address affordability challenges that have prevented many Americans from filling prescriptions.
Woman injecting a syringe of medicine into her stomach (David Petrus Ibars/Getty Images / Getty Images)
“That’s solving the problem for a quarter of Americans who can’t pick up a prescription when they get to the pharmacy counter because they can’t afford it right now,” Klomp said.
The price drop reflects a broader effort to align drug costs more closely with international benchmarks while increasing competition in the market. GLP-1 medications, commonly used for diabetes and weight management, have become a focal point in the affordability debate as demand continues to climb.
Advertisement
eMed chief wellness officer Tom Brady and eMed CEO Linda Yaccarino discuss GLP-1 market growth and the company’s latest funding round on ‘Mornings with Maria.’
Klomp suggested the changes extend beyond a single drug class, pointing to similar trends in other treatments where costs have historically been a barrier to access.
“If you want to grow your family, you need to pick up fertility medicine again. You’re paying about half for those drugs, saving you thousands of dollars per cycle of treatment than you were just a couple months ago,” he said.
The shifts come as policymakers look for ways to reduce out-of-pocket costs while maintaining long-term sustainability in federal health care programs.
Advertisement
“[Trump’s] delivering on affordability for every American family to be their healthiest self,” Klomp said.
PE-backed firm teams up with Royal Fulfillment for centres in New Jersey, Chicago and Los Angeles
fulfilmentcrowd’s CEO Lee Thompson(Image: fulfilmentcrowd)
Logistics tech specialist fulfilmentcrowd is expanding its US network with new centres in New Jersey, Chicago and Los Angeles.
Chorley-based fulfilmentcrowd has teamed up with American group Royal Fulfillment on the centres designed to “support high-volume eCommerce and B2B distribution across the United States” and to offer coast-to-coast coverage for brands serving the US market. They will replace the group’s two previous US sites.
Royal Fulfillment is a family-run operator with more than 18 years of industry experience. Its centres can handle both direct-to-consumer and large-scale retail distribution, and the business has worked with major retailers such as Amazon, Walmart and Sephora.
Advertisement
Fulfilmentcrowd says its expanded US network will give its customers access to a wider range of US shipping services, including through carriers such as USPS, FedEx and DHL
Lee Thompson, CEO at fulfilmentcrowd, said: “The US is a critical growth market for many of our clients. With this three-centre network, we’re aiming to reduce operational friction at scale, giving global brands the ability to operate domestically across the US with speed, flexibility and cost control built in.”
He added: “This is about more than just adding locations. These centres add to a network that already reflects how modern brands operate: omnichannel, fast-moving and customer-first. Now we can support these requirements across the entire United States.”
Varney & Co. host Stuart Varney warns NYC Mayor Zohran Mamdani’s tax proposals could drive jobs, capital and residents out of New York as a $12.6B deficit looms.
JPMorgan Chase CEO Jamie Dimon warned that New York City and other cities with high taxes and regulatory burdens run the risk of losing businesses and workers to locales with more hospitable business climates.
Dimon released his annual letter to shareholders on Monday in conjunction with the firm’s 2025 annual report and said that companies need to weigh the benefits of operating in places like New York City against areas with lower taxes on businesses and individuals.
Advertisement
“No matter who you are, you need to deal with reality and the truth. The truth is that while New York City has much going for it, particularly for financial companies (because of extraordinary local talent), it also has the highest city and state corporate taxes and the highest individual income and state taxes,” Dimon wrote.
“People often make this a moral or loyalty issue, but it is not. Companies need to remain competitive in this very tough, fast-moving world. And higher taxes lower returns on capital and less competitiveness by their nature,” he said.
JPMorgan Chase CEO Jamie Dimon said that cities and states have to compete to keep businesses in their jurisdictions. (Alexander Tamargo/Getty Images for America Business Forum)
Dimon said while companies relocating their headquarters or significant aspects of their operations to states with more favorable tax and regulatory regimes may be easier to track, those shifts happen at the employee level as well and can amount to significant moves for the workforce.
Advertisement
“Additionally, individuals vote with their feet – you can already see a fairly large exodus of people and jobs out of some states with high taxes and high expenses (often due to high taxes and regulatory burdens). Sometimes you see companies leaving states, but migration also shows up in shifts of employees out of certain states,” Dimon wrote.
JPMorgan Chase has expanded its presence in Texas while its headcount has declined in New York City. (Tim Clayton/Corbis via Getty Images)
He explained how that dynamic has played out at JPMorgan, which has expanded its footprint in a low-tax state like Texas and will probably continue to do so.
“For example, while New York City is still our company’s global headquarters, we have shrunk our headcount in the city, from 30,000 a decade ago to 24,000 today, and increased our headcount in Texas, from 26,000 in 2015 to 32,000 today. This trend will likely continue,” Dimon said.
The JPMorgan CEO said that he has seen an exodus of corporations out of New York City before that was driven in part by the business climate, adding it can pose significant problems for city governments.
“Sometimes this can be a disaster for a city. I am reminded that in the 1970s, nearly half of the 125 Fortune 500 companies based in New York City left,” he wrote. “While mergers accounted for some departures, the price of doing business in New York City accounted for most: cost of taxes, office rents, labor and so on.”
You must be logged in to post a comment Login